Cardiac stimulant activity of bark and wood of Premna serratifolia

Authors

  • Rekha Rajendran Department of Pharmacognosy, Mohamed Sathak A. J. College of Pharmacy, Medavakkam, Chennai 600119
  • Suseela L Department of Pharmacognosy, Madras Medical College, Chennai 600003
  • Meenakshi Sundaram R Department of Pharmacognosy, Mohamed Sathak A. J. College of Pharmacy, Medavakkam, Chennai 600119
  • Saleem Basha N Department of Pharmacognosy, Mohamed Sathak A. J. College of Pharmacy, Medavakkam, Chennai 600119

DOI:

https://doi.org/10.3329/bjp.v3i2.952

Keywords:

Adrenaline, Cardiac stimulant, Digoxin, Premna serratifolia

Abstract

Premna serratifoliaLin., (Verbenaceae) contains alkaloids and iridoid glycoside and is believed to prevent cardiovascular disease. The stem-bark and stem-wood were extracted with 95% ethanol and distilled water. These extracts were screened for their effects by Isolated Frog Heart Perfusion Technique and biochemical parameters in heart tissue and serum of albino rats after administering the extracts for 7 days. The ethanol extract produced significant positive ionotropic and negative chronotropic actions similar to that of digoxin on frog heart and its effect was inhibited by nifedipine but not by propranolol. A significant decrease in membrane Na+K+ATPase and Mg2+ATPase and an increase in Ca2+ATPase further confirmed its cardiotonic activity. Aqueous extract produced positive ionotropic and chronotropic effects similar to that of adrenaline and its effect was antagonized by propranolol and nifedipine. The results suggest that the ethanol extract produced cardiotonic effect and the aqueous extract produced beta-adrenergic effect.

Downloads

Download data is not yet available.
Abstract
1340
Download
1361 Read
327

References

Al-Shabanah O, Mansour M, El-Kashef H, Al-Bekairi A. Captopril ameliorates myocardial and hematological toxicities induced by adriamycin. Biochem Mol Biol Int. 1998; 45: 41927.

Anonymous. The wealth of India - Dictionary of Indian raw materials and industrial products - Raw Materials. Vol. 8. New Delhi, Council of Scientific and Industrial Research, 1972, p 240.

Akera T, Brody TM. The role of Na+K+ATPase in the ionotropic action of digitalis. Pharmacol Rev. 1977; 29: 187-220.

Beller GA, Smith TW, Abelmann WH, Haber E, Hood WB Jr. Digitalis intoxication: A prospective clinical study with serum level correlations. N Engl J Med. 1971; 284: 989-97.

Bassett AL, Chakko S, Epstein M. Are calcium antagonists proarrhythmic? J Hypertens. 1997; 15: 915-23.

Bonting SL. Sodium-potassium activated adenosine triphosphatase and cation transport. In: Membrane and ion transport. Bittar EE (ed). London, Wiley-Interscience, 1970.

Chen CL, Sangiah S, Patterson E, Berlin KD, Garrison GL, Dunn W, et al. Effects of BRB-I-28, a novel antiarrhythmic agent and its derivatives on cardiac Na+K+ATPase, Mg2+ATPase activities and contractile force. Res Commu Chem Pathol Pharmacol. 1992; 78: 3-16.

Chopra S, Pillai KK, Husain SZ, Giri DK. Propolis protects against doxorubicin-induced myocardiopathy in rats. Exp Mol Pathol. 1995; 62: 190-98.

Evans WC. Pharmacognosy. 14th ed. London, WB Saunders Company Ltd., 1996, pp 229-493.

Fabiato A. Time and calcium dependence of activation and inactivation of calcium-induced release of calcium from the sarcoplasmic reticulum of a skinned canine cardiac Purkinjee cell. J Gen Physiol. 1985; 85: 247-89.

Gopal RH, Purushothaman KK. Effect of plant isolates on coagulation of blood: An in vitro study. Bull Med Ethnobot Res. 1984; 5: 171-77.

Goto A, Yamada K, Yagi N, Yoshioka M, Sugimoto T. Physiology and pharmacology of endogenous digitalis-like factors. Pharmacol Rev. 1992; 44: 377-99.

Hjerten S, Pan H. Purification and characterization of two forms of low affinity Ca2+ATPase from erythrocyte membranes. Biochem Biophys Acta. 1983; 728: 281-88.

Kelly RA, Smith TW. Pharmacological treatment of heart failure. In: Goodman Gillmans The pharmacological basis of therapeutics. 9th ed. McGraw-Hill, 1996, p 811.

King J. The dehydrogenases or oxidoreductases. Lactate dehydrogenase. In: Practical clinical enzymology. London, Van Nostrand, D. Company Ltd, 1965.

King J. The transferases- alanine and aspartate transaminases. In: Practical clinical enzymology. London, Van Nostrand, D. Company Ltd, 1965.

Kitada Y, Narimatsu A, Suzuki R, Endoh M, Taira N. Does the positive ionotropic action of a novel cardiotonic agent, MCI-154, involve mechanisms other than cyclic AMP? J Pharmacol Exp Ther. 1987; 243: 639-45.

Kokko and Tannen (ed.). Fluid and electrolyte abnormalities of disease. In: Fluids and Electrolytes. 2nd ed. Philadelphia, WB Saunders Company, 1990, pp 647-80.

Lees GH. Inhibition of sodium potassium ATPase: A potentially ubiquitous mechanism contributing to central nervous system neuropathology. Brain Res Rev. 1991; 16: 283-300.

McGarry SJ, Williams AJ. Digoxin activates sarcoplasmic reticulum Ca2+ release channels: a possible role in cardiac ionotropy. Br J Pharmacol. 1993; 108: 1043-50.

Muralidharan A, Dhananjayan R. Cardiac stimulant activity of Ocimum basilicum Linn. extracts. Indian J Pharmacol. 2004; 36: 163-66.

Natkarni KM. Indian Materia Medica plants 3rd ed. Vol I. Bombay, Popular Prakashan, 1976, pp 1009-10.

Ohinishi T, Suzuki T, Suzuki Y, Ozawa K. Comparative study of plasma membrane Mg2+ATPase activities in normal, regenerating and malignant cells. Biochem Biophys Acta. 1982; 684: 67-74.

Okinaka S, Kumagi H, Ebashi S, Sugita H, Momoi H, Toyokura Y, et al. Serum creatine phosphokinase. Activity in progressive muscular dystrophy and neuromuscular diseases. Arch Neurol. 1961; 4: 520-25.

Poole-Wilson P, Coluci N, Massie B, Chatterjee K, Coats A. Heart failure: Scientific principles and clinical practices. New York, Churchill Livingstone, 1997.

Rathore RS, Prakash A, Singh PP. Preliminary study of anti-inflammatory and anti-arthritic activity. Rheumatism 1977; 12: 130.

Tripathi KD. Cardiac glycosides and drugs for CHF. In: Essentials of medical pharmacology, 4th ed. New Delhi, Jaypee Brothers Medical Publishers Pvt. Ltd., 2001, p 120.

Trivedi PC, Nehra S. Herbal drugs and biotechnology, Plant which cures heart disease. Trivedi PC (ed). Jaipur, Pointer Publishers, 2004, p. 3.

Wang SQ, Song LS, Lakatta EG, Cheng H. Ca2+ signaling between single L-type Ca2+ channels and rynodine receptors in heart cells. Nature 2001; 410: 592-96.

Yoganarasimhan SN. Medicinal plants of India Tamil Nadu. Vol 2. India, Regional Research Institute Bangalore, 2000, p 441.

Downloads

Additional Files

Published

2008-07-27

How to Cite

Rajendran, R., S. L, M. S. R, and S. B. N. “Cardiac Stimulant Activity of Bark and Wood of Premna Serratifolia”. Bangladesh Journal of Pharmacology, vol. 3, no. 2, July 2008, pp. 107-13, doi:10.3329/bjp.v3i2.952.

Issue

Vol. 3 No. 2 (2008)

Section

Research Articles

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).